Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 12:55PM ET
6.40
Dollar change
-0.13
Percentage change
-2.05
%
IndexRUT P/E- EPS (ttm)-1.34 Insider Own3.29% Shs Outstand147.56M Perf Week14.63%
Market Cap943.96M Forward P/E- EPS next Y-0.93 Insider Trans-0.54% Shs Float142.73M Perf Month20.46%
Income-195.24M PEG- EPS next Q-0.26 Inst Own92.16% Short Float5.75% Perf Quarter47.04%
Sales177.28M P/S5.32 EPS this Y28.53% Inst Trans1.71% Short Ratio7.03 Perf Half Y88.68%
Book/sh1.52 P/B4.22 EPS next Y16.26% ROA-30.60% Short Interest8.20M Perf Year36.09%
Cash/sh1.65 P/C3.88 EPS next 5Y- ROE-66.69% 52W Range2.28 - 6.70 Perf YTD30.54%
Dividend Est.- P/FCF- EPS past 5Y-32.91% ROI-44.55% 52W High-4.53% Beta1.48
Dividend TTM- Quick Ratio3.38 Sales past 5Y27.46% Gross Margin50.91% 52W Low180.54% ATR (14)0.45
Dividend Ex-Date- Current Ratio3.52 EPS Y/Y TTM1.86% Oper. Margin-93.79% RSI (14)64.72 Volatility11.33% 9.32%
Employees709 Debt/Eq1.00 Sales Y/Y TTM-1.34% Profit Margin-110.13% Recom1.50 Target Price7.42
Option/ShortYes / Yes LT Debt/Eq0.96 EPS Q/Q37.46% Payout- Rel Volume0.71 Prev Close6.53
Sales Surprise15.41% EPS Surprise23.48% Sales Q/Q22.46% EarningsNov 07 AMC Avg Volume1.17M Price6.40
SMA2016.08% SMA5024.70% SMA20057.41% Trades Volume453,595 Change-2.05%
Date Action Analyst Rating Change Price Target Change
Jul-05-23Resumed JP Morgan Overweight $15
Jan-05-23Initiated Scotiabank Sector Outperform $15
Dec-21-22Upgrade Piper Sandler Neutral → Overweight $7.50 → $14
Aug-25-22Initiated Credit Suisse Underperform $8
Jun-03-22Initiated Piper Sandler Neutral $7.50
Feb-16-22Reiterated JP Morgan Overweight $75 → $50
Feb-16-22Reiterated Goldman Neutral $54 → $21
Feb-16-22Reiterated BTIG Research Buy $35 → $30
Feb-16-22Reiterated BofA Securities Buy $40 → $32
Oct-15-21Resumed Cowen Outperform
Today 07:30AM
Nov-29-24 09:40AM
Nov-25-24 01:55PM
Nov-15-24 09:55AM
Nov-08-24 10:18AM
02:29AM Loading…
02:29AM
Nov-07-24 06:30PM
06:15PM
05:11PM
04:05PM
07:30AM
Nov-06-24 07:28AM
Oct-09-24 04:05PM
Oct-04-24 04:35AM
Aug-29-24 07:30AM
04:03PM Loading…
Aug-22-24 04:03PM
Aug-01-24 07:00PM
06:20PM
05:23PM
04:05PM
Jul-21-24 06:00AM
Jul-15-24 12:00PM
Jul-11-24 04:05PM
May-31-24 07:30AM
May-29-24 04:05PM
May-25-24 08:30AM
May-24-24 09:58AM
May-23-24 06:00AM
May-16-24 02:30PM
May-08-24 06:43PM
12:19PM Loading…
12:19PM
03:54AM
May-07-24 07:30PM
05:47PM
05:40PM
04:37PM
04:05PM
Apr-26-24 10:02AM
Apr-17-24 04:05PM
Apr-02-24 04:05PM
Mar-27-24 04:30PM
08:30AM
Mar-11-24 12:01AM
Feb-22-24 04:05PM
Feb-15-24 10:09AM
06:37AM
Feb-14-24 05:16PM
04:43PM
04:05PM
Feb-13-24 02:23AM
Feb-12-24 09:16AM
Jan-29-24 04:05PM
Dec-27-23 04:05PM
Dec-12-23 05:50AM
Dec-11-23 03:30PM
Dec-09-23 08:30AM
Dec-05-23 07:30AM
Nov-10-23 01:52PM
Nov-09-23 04:17PM
04:05PM
Nov-07-23 07:30AM
Nov-02-23 04:05PM
Oct-26-23 10:02AM
Oct-17-23 07:57AM
Sep-27-23 05:14AM
Sep-13-23 07:30AM
Aug-30-23 04:30PM
Aug-28-23 11:53PM
Aug-24-23 10:29AM
Aug-02-23 05:35PM
04:30PM
04:05PM
Jul-29-23 12:12AM
Jul-19-23 08:52AM
Jul-10-23 04:05PM
Jun-24-23 03:19PM
Jun-16-23 05:02PM
Jun-02-23 10:15AM
07:34AM
May-29-23 08:08AM
May-26-23 09:45AM
May-24-23 04:05PM
May-23-23 09:54AM
May-15-23 07:50AM
May-12-23 08:00AM
May-09-23 07:30AM
May-04-23 09:13AM
May-03-23 05:25PM
04:05PM
Apr-27-23 10:02AM
Apr-26-23 10:02AM
Apr-25-23 04:05PM
Apr-24-23 09:40AM
Apr-18-23 12:10PM
Apr-12-23 07:30AM
Apr-06-23 04:05PM
Mar-29-23 04:20PM
Mar-27-23 09:40AM
Mar-16-23 11:41AM
Mar-10-23 10:42AM
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PISKEL KYLEChief Financial OfficerNov 18 '24Sale4.982481,235154,330Nov 19 06:45 PM
BOBULSKY SUSANChief Commercial Officer, MRDOct 08 '24Option Exercise1.985,0009,900253,290Oct 10 05:47 PM
Taylor Stacy LSVP and General CounselAug 22 '24Sale4.5026,922121,079139,365Aug 23 04:27 PM
STACY L TAYLOROfficerAug 22 '24Proposed Sale4.5026,922121,079Aug 22 04:18 PM
NEUPERT PETER MDirectorMar 12 '24Option Exercise0.8415,00012,600169,296Mar 13 05:55 PM
PISKEL KYLEPrincipal Accounting OfficerMar 05 '24Sale3.437,72726,504123,318Mar 06 07:43 PM
Taylor Stacy LSVP and General CounselMar 05 '24Sale3.4313,38145,963166,287Mar 06 07:42 PM
LO FRANCISChief People OfficerMar 05 '24Sale3.4314,70050,439253,745Mar 06 07:42 PM
BENZENO SHARONChief Commercial Ofc Imm MedMar 05 '24Sale3.4429,390100,994327,415Mar 06 07:42 PM
RUBINSTEIN JULIEPresidentMar 05 '24Sale3.4739,070135,764472,754Mar 06 07:41 PM
PETERSON TYCHOChief Financial OfficerMar 05 '24Sale3.4415,45653,169531,553Mar 06 07:40 PM
ROBINS CHAD MCEO and ChairmanMar 05 '24Sale3.4348,673167,0072,576,701Mar 06 07:40 PM
BOBULSKY SUSANChief Commercial Officer, MRDMar 05 '24Sale3.4412,99144,629248,290Mar 06 07:39 PM
NEUPERT PETER MDirectorDec 13 '23Option Exercise0.84100,00084,000122,968Dec 15 04:21 PM